Tag: sirona biochem

January 5, 2021

Biotech Outlook 2021: IPO Craze to Continue Amid COVID-19 Recovery

After an up-and-down year for the market, what’s in store for the biotech space and its investors in 2021?
April 30, 2020

How the Global Skincare Market is Embracing Skin Lightening Products

As skincare product demand drives research, established brands have the opportunity to leverage scientific advancements to provide safe and effective...
August 28, 2018

Sirona Biochem Receives US$500,000 Payment from Wanbang Biopharmaceuticals

Sirona Biochem (TSXV:SBM) has announced it has received the US$500,0000 payment from Wanbang Biopharmaceuticals for approval by the China and...
July 12, 2018

Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial

Sirona Biochem (TSXV:SBM) announced today that partner, Jiangsu Wanbang Biopharmaceuticals, has confirmed the Investigational New Drug (IND) submission to China’s Food...
January 31, 2018

Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference

Sirona Biochem (TSXV: SBM)  announced that the Company is developing an anti-wrinkle therapy. The compound, LIP-01, was discovered to have a novel mechanism...
October 25, 2017

Sirona Biochem Details New Round of Private Financing

Sirona Biochem announced it arranged non-brokered private placement for gross proceeds of $535,000.
September 27, 2017

Sirona Subsidiary Receives Final Loan Tranche

Sirona Biochem announced its French subsidiary TFChem received the final tranche of 1.2 million from a French public investment bank.